Overcoming Resistance to First/Second Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and ALK Inhibitors in Oncogene-Addicted Advanced Non-Small Cell Lung Cancer
Therapeutic Advances in Medical Oncology - United States
doi 10.1177/1758834016631531
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 16, 2016
Authors
Publisher
SAGE Publications